Aquestive Therapeutics Inc (AQST)
3.26
-0.10
(-3.12%)
USD |
NASDAQ |
May 02, 11:09
Aquestive Therapeutics Price: 3.26 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 3.35 | 3.47 | 3.20 | 3.365 | 2.040M |
Apr 30, 2024 | 3.59 | 3.65 | 3.06 | 3.36 | 4.011M |
Apr 29, 2024 | 3.91 | 3.950 | 3.24 | 3.735 | 7.648M |
Apr 26, 2024 | 4.00 | 4.250 | 3.95 | 4.07 | 2.987M |
Apr 25, 2024 | 3.93 | 4.01 | 3.775 | 3.93 | 1.936M |
Apr 24, 2024 | 4.25 | 4.280 | 3.90 | 3.90 | 2.148M |
Apr 23, 2024 | 4.38 | 4.50 | 4.24 | 4.28 | 1.700M |
Apr 22, 2024 | 4.18 | 4.39 | 4.01 | 4.38 | 1.826M |
Apr 19, 2024 | 4.38 | 4.54 | 4.05 | 4.105 | 2.341M |
Apr 18, 2024 | 4.00 | 4.51 | 3.93 | 4.50 | 5.785M |
Apr 17, 2024 | 3.94 | 4.05 | 3.82 | 3.92 | 2.448M |
Apr 16, 2024 | 3.88 | 3.89 | 3.72 | 3.85 | 1.887M |
Apr 15, 2024 | 4.05 | 4.10 | 3.83 | 3.94 | 1.345M |
Apr 12, 2024 | 4.07 | 4.11 | 3.75 | 3.91 | 3.512M |
Apr 11, 2024 | 4.34 | 4.38 | 4.075 | 4.09 | 2.848M |
Apr 10, 2024 | 4.00 | 4.145 | 3.984 | 4.07 | 1.187M |
Apr 09, 2024 | 4.06 | 4.165 | 3.93 | 4.09 | 1.665M |
Apr 08, 2024 | 4.10 | 4.15 | 3.96 | 4.07 | 1.373M |
Apr 05, 2024 | 4.19 | 4.295 | 3.99 | 4.10 | 2.216M |
Apr 04, 2024 | 4.24 | 4.33 | 3.90 | 4.16 | 3.560M |
Apr 03, 2024 | 4.16 | 4.51 | 4.06 | 4.38 | 4.068M |
Apr 02, 2024 | 4.06 | 4.25 | 4.01 | 4.14 | 2.467M |
Apr 01, 2024 | 4.29 | 4.359 | 4.065 | 4.13 | 1.940M |
Mar 28, 2024 | 4.27 | 4.48 | 4.22 | 4.26 | 7.208M |
Mar 27, 2024 | 4.13 | 4.217 | 3.99 | 4.10 | 2.407M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.63
Minimum
Jul 01 2022
9.09
Maximum
Sep 11 2020
3.424
Average
3.56
Median
Jul 29 2019
Price Benchmarks
Lifecore Biomedical Inc | 6.31 |
Harrow Inc | 10.47 |
Akebia Therapeutics Inc | 1.245 |
89bio Inc | 8.90 |
Geron Corp | 3.91 |
Price Related Metrics
PS Ratio | 4.239 |
Earnings Yield | -4.73% |
Market Cap | 238.96M |